Investment accounts
Authorised and regulated by the UK’s FCA to provide investment accounts, we are bound by CASS rules to segregate and protect client assets.
From a lab trial to a healthcare breakthrough: what does it take for innovative technologies to enter the market and make a life-changing health solution available to millions of patients? How to accelerate the discovery and implementation of health innovation and turn cutting-edge scientific research into a profitable business? And how can investors take advantage of opportunities in this sector at an early stage, while enabling the latest proven technologies transform health outcomes and make a real positive impact on the society?
Dolfin and Aescuvest present a panel discussion bringing together leading European scientists with healthcare investors and entrepreneurs, to explore technologies and processes that drive better outcomes, for patients and investors alike.
Dolfin clients, including Private and Institutional investors, External Asset Managers; VCs, who are interested to identify investment opportunities in the Healthcare sector as well as C-Suite executives from the biotech, health care and life sciences industries.
16:30 | Doors open and registration |
17:00 | Welcome remarks, Dolfin |
17:05 | Keynote speech, Dr Kurt Höller, Director of Business Creation at EIT Health |
17:15 | Panel discussion and Q&A |
18:15 | Closing remarks, Dr Patrick Pfeffer, CEO and founder of Aescuvest |
18:30 | Reception |
Dolfin’s investment accounts safeguard securities and cash, while ensuring you or your clients can take full advantage of multi-asset, multi-currency, and multi-strategy investments.
Learn moreFounded as a London-based wealth boutique in 2013, today we’re a diversified financial services firm with an international presence and our own bespoke technology platform.
Learn moreWe pride ourselves on our ability to help. Please get in touch.
Contact us